Communication, Drug Development and White Paper

Lisata collaborates with GATC Health on drug development

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.

Drug Development

Drug Development Communication Hospitals Packaging

Why security-first design is the fix to stalling AI pilot tools

pharmaphorum

JULY 2, 2025

Skip to main content Wednesday 2 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development

Alzheimer’s disease biomarkers galvanise rocky drug development space

Pharmaceutical Technology

DECEMBER 7, 2022

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanise rocky drug development space appeared first on Pharmaceutical Technology.

Drug Development

Drug Development Communication Immunity Immunization

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

FEBRUARY 23, 2023

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited. Please check your email to download the Whitepaper.

Drug Development

Drug Development Compounding Dosage Packaging

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

JUNE 26, 2025

Particularly beneficial in the early drug discovery phase, AI can help identify potential drug targets more effectively than traditional methods, accelerating the initial stages of drug development by quickly sifting through large volumes of data. You will receive an email shortly.

Compounding

Compounding Drug Development Communication Packaging

Alzheimer’s disease biomarkers galvanize rocky drug development space

Pharmaceutical Technology

DECEMBER 7, 2022

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services. The post Alzheimer’s disease biomarkers galvanize rocky drug development space appeared first on Pharmaceutical Technology.

Drug Development

Drug Development Communication Immunity Immunization

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

JUNE 6, 2025

wants to ensure the ensuing the US does not lag behind other countries in drug development. We want to make sure we are getting rid of the regulatory impediments [that stop drugs getting to market],” RFK Jr stated. We may still continue to send you service-related and other non-promotional communications.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Hospitals Drug Development

MD Anderson and Xilis partner to expedite new cancer therapies development

Pharmaceutical Technology

FEBRUARY 16, 2023

It may offer opportunities for third-party collaborations to guide the new cell therapies and drugs development, if successful. It enables quick evaluation of a patient tumour response to a range of cancer drug modalities within 14 days of obtaining harvested samples of tumour cells.

Drug Development

Drug Development Communication

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

JUNE 23, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

Actio gains $66m to advance small molecule therapeutics pipeline

Pharmaceutical Technology

JUNE 19, 2025

Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Drug Development Pharmaceutical Manufacturing

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

JUNE 23, 2025

We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy. Sign up for our daily news round-up!

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Hospitals

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Pharmaceutical Technology

JUNE 19, 2025

Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drug development in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Drug Development Pharmaceutical Manufacturing

Novartis concludes Regulus Therapeutics acquisition

Pharmaceutical Technology

JUNE 26, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

Revolution Medicines partners Royalty Pharma on $2bn funding

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Vaccines

Vaccines Pharmaceutical Manufacturing Communication Hospitals

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Pharmaceutical Technology

JUNE 26, 2025

A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from the brink with a licensing deal potentially rising to $4bn for an autoimmune drug developed by Chinese biotech RemeGen. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

Draig secures $140m for neuropsychiatric disorder therapies

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Navamedic signs agreement to acquire dne pharma

Pharmaceutical Technology

JUNE 24, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Pharmaceutical Manufacturing

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Pharmaceutical Technology

JUNE 24, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Hospitals

Hospitals Packaging Communication Pharmaceutical Manufacturing

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

JUNE 23, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Labelling

Labelling Packaging Communication Hospitals

Medera and Novoheart collaborate on mini-heart models for HLHS

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Mayo Clinic

Mayo Clinic Packaging Communication Hospitals

NextCure and Simcere partner to develop SIM0505 for solid tumours

Pharmaceutical Technology

JUNE 17, 2025

Syngene’s expertise in the field is covered in this white paper. “SIM0505 is a significantly differentiated CDH6 targeting ADC candidate independently developed by Simcere Zaiming. In January 2025, AbbVie and Simcere Zaiming entered an option-to-license agreement for the development of SIM0500.

Communication

Communication Hospitals Packaging Drug Development

EHDS regulation will depend on strong patient confidence

Pharmaceutical Technology

JUNE 25, 2025

Communication between European Union (EU) member states is ongoing to finalise the details of the legislation, but at its core, the EHDS will provide a single registry of patient data from across the continent. Trust is something that you earn, so how we communicate what’s coming out of this directive is very important.

Communication

Communication Hospitals Packaging Pharmaceutical Companies

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

JUNE 24, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Compounding

Compounding Packaging Online Pharmacies Communication

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development

Drug Development Dosage Pharmaceutical Manufacturing Communication

Alzheimer’s R&D resurgence driven by $16.8bn in acquisitions in 2025YTD

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Packaging

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

FEBRUARY 8, 2023

Despite the challenges that drug developers must overcome to produce gene therapies for rare diseases, Hart underscored the FDA’s intent to encourage more innovation in this space. “We Therefore, the good news is we have flexibilities that can be offered to see drug development for these diseases.”

Documentation

Documentation Drug Development Communication

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

. <p>Early Access Programs (EAPs) are a pathway for pharmaceutical companies to provide innovative drugs to patients living with serious conditions. These treatments may still be in development or already have approval somewhere in the world. </p> </p> By Tanner Pharma Group.

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars

Navigating uncertainty: the future of vaccine oversight amid CDC firings

Pharmaceutical Technology

JUNE 25, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Vaccines

Vaccines Hospitals Packaging Communication

Bridging the gap: A comprehensive approach to social determinants of health

Pharmaceutical Technology

JUNE 23, 2025

Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. The parallel shift to using real-world data (RWD) provides the ideal framework for further investigation into SDoH. Sign up for our daily news round-up!

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Pharmaceutical Manufacturing Communication

Can the FDA keep the momentum going for rare disease drug approvals?

Pharmaceutical Technology

JANUARY 22, 2023

Nicklas Westerholm, the CEO and president of orphan drug developer Egetis Therapeutics, says disease awareness amongst paediatric neurologists and endocrinologists is low for MCT8 deficiency. The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities. on placebo.

Communication

Communication Dosage Drug Development

Customs simplified: the need to streamline pharma shipments

Pharmaceutical Technology

JUNE 12, 2025

Outsourcing is now a fundamental part of drug development and distribution. Outsourcing is now a fundamental part of drug development and distribution. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Health and Personal Care Stores

Health and Personal Care Stores Communication Drug Development Packaging

Teijin Pharma and Novartis sign licence deal for kidney disease candidate

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is also eligible for up to $200m in potential development and commercial milestone payments along with further additional sales milestones as well as tiered annual net sales royalties. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.

Compounding

Compounding Communication Drug Development

AbbVie and Capsida partner for gene therapies to treat eye diseases

Pharmaceutical Technology

FEBRUARY 24, 2023

Combining AbbVie’s expertise in eye disease drug development and commercialisation with Capsida’s fully integrated next-generation AAV engineering platform and manufacturing capabilities offers the potential to provide novel therapies enabling unprecedented benefit to patients with serious eye diseases.”

Communication

Communication Drug Development

Solid Biosciences partners with Phlox for cardiac disease therapies

Pharmaceutical Technology

JANUARY 12, 2023

Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM). Solid Biosciences stated that the partnership boosts its scientific capabilities along with commercial potential in cardiac therapy.

Communication

Communication Drug Development

Low-code/no-code platforms and SaaS: the next evolution in clinical trial technology

Pharmaceutical Technology

DECEMBER 13, 2022

Prominent SaaS systems were a huge inspiration, McVeigh says, but the technical challenge presented by the drug development world came with different demands. At the same time, Suvoda has built a large API surface on top of the platform architecture that will simplify integrations with other eClinical systems.

Communication

Communication Drug Development

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Labelling Communication

Pathbreakers: The journey of first generics

Pharmaceutical Technology

MAY 3, 2023

In a white paper titled “Access Denied: Why New Generics Are Not Reaching America’s Seniors,” the AAM analysis indicates that patients may wait up to three years for first generic competitors to costly brands. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.

Generic Medicine

Generic Medicine Drug Development Communication Diabetes

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Labelling Communication

Lisata collaborates with GATC Health on drug development

Why security-first design is the fix to stalling AI pilot tools

Trending Sources

Alzheimer’s disease biomarkers galvanise rocky drug development space

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

How AI and machine learning are transforming drug discovery

Alzheimer’s disease biomarkers galvanize rocky drug development space

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

MD Anderson and Xilis partner to expedite new cancer therapies development

EC approves argenx’s efgartigimod alfa for CIDP treatment

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Actio gains $66m to advance small molecule therapeutics pipeline

Harbour BioMed partners Otsuka on new T-cell therapy

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Novartis concludes Regulus Therapeutics acquisition

Revolution Medicines partners Royalty Pharma on $2bn funding

DoH – Abu Dhabi and Sanofi link for vaccine development

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Draig secures $140m for neuropsychiatric disorder therapies

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Navamedic signs agreement to acquire dne pharma

Zambon gains Chinese regulatory authority approval for Fluimucil IV

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Medera and Novoheart collaborate on mini-heart models for HLHS

NextCure and Simcere partner to develop SIM0505 for solid tumours

EHDS regulation will depend on strong patient confidence

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

The rising importance of containment in small molecule drug development

Alzheimer’s R&D resurgence driven by $16.8bn in acquisitions in 2025YTD

FDA suggests ways to curb constraints with rare disease gene therapy trials

The Brazilian pharma market: Key information and what may change

Navigating uncertainty: the future of vaccine oversight amid CDC firings

Bridging the gap: A comprehensive approach to social determinants of health

Can the FDA keep the momentum going for rare disease drug approvals?

Customs simplified: the need to streamline pharma shipments

Teijin Pharma and Novartis sign licence deal for kidney disease candidate

AbbVie and Capsida partner for gene therapies to treat eye diseases

Solid Biosciences partners with Phlox for cardiac disease therapies

Low-code/no-code platforms and SaaS: the next evolution in clinical trial technology

The “Medical Bypass”: new drugs to strike obesity

Pathbreakers: The journey of first generics

The “Medical Bypass”: new drugs to strike obesity

Stay Connected